全文获取类型
收费全文 | 2725篇 |
免费 | 402篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 117篇 |
妇产科学 | 62篇 |
基础医学 | 243篇 |
口腔科学 | 43篇 |
临床医学 | 457篇 |
内科学 | 754篇 |
皮肤病学 | 62篇 |
神经病学 | 275篇 |
特种医学 | 312篇 |
外科学 | 336篇 |
综合类 | 53篇 |
一般理论 | 1篇 |
预防医学 | 165篇 |
眼科学 | 39篇 |
药学 | 145篇 |
中国医学 | 1篇 |
肿瘤学 | 85篇 |
出版年
2023年 | 59篇 |
2022年 | 19篇 |
2021年 | 38篇 |
2020年 | 98篇 |
2019年 | 28篇 |
2018年 | 103篇 |
2017年 | 82篇 |
2016年 | 87篇 |
2015年 | 77篇 |
2014年 | 131篇 |
2013年 | 156篇 |
2012年 | 109篇 |
2011年 | 85篇 |
2010年 | 114篇 |
2009年 | 138篇 |
2008年 | 97篇 |
2007年 | 105篇 |
2006年 | 99篇 |
2005年 | 70篇 |
2004年 | 65篇 |
2003年 | 59篇 |
2002年 | 58篇 |
2001年 | 53篇 |
2000年 | 37篇 |
1999年 | 32篇 |
1998年 | 87篇 |
1997年 | 103篇 |
1996年 | 85篇 |
1995年 | 83篇 |
1994年 | 54篇 |
1993年 | 61篇 |
1992年 | 35篇 |
1991年 | 35篇 |
1990年 | 50篇 |
1989年 | 77篇 |
1988年 | 64篇 |
1987年 | 39篇 |
1986年 | 41篇 |
1985年 | 38篇 |
1984年 | 22篇 |
1983年 | 23篇 |
1982年 | 26篇 |
1981年 | 22篇 |
1980年 | 23篇 |
1979年 | 16篇 |
1978年 | 17篇 |
1977年 | 14篇 |
1976年 | 14篇 |
1975年 | 14篇 |
1971年 | 12篇 |
排序方式: 共有3166条查询结果,搜索用时 15 毫秒
71.
Day‐case device implantation—A prospective single‐center experience including patient satisfaction data
下载免费PDF全文
![点击此处可从《Pacing and clinical electrophysiology : PACE》网站下载免费的PDF全文](/ch/ext_images/free.gif)
72.
An interesting case of wide QRS tachycardia with right bundle branch block morphology: What is the mechanism?
下载免费PDF全文
![点击此处可从《Pacing and clinical electrophysiology : PACE》网站下载免费的PDF全文](/ch/ext_images/free.gif)
73.
Narrow QRS tachycardia with apparent concentric atrial activation pattern: What is the mechanism?
下载免费PDF全文
![点击此处可从《Pacing and clinical electrophysiology : PACE》网站下载免费的PDF全文](/ch/ext_images/free.gif)
74.
75.
Monique Lhussier HND MSc PhD Simon Eaton BMedSci BMBS FRCP DM CertMEd Natalie Forster BA PGCert Mathew Thomas BA Sue Roberts MBBS MSc FRCP Susan M Carr BA MSc PhD 《Health expectations》2015,18(5):605-624
Objective
This article focuses on approaches within clinical practice that seek to actively involve patients with long‐term conditions (LTCs) and how professionals may understand and implement them. Personalized care planning is one such approach, but its current lack of conceptual clarity might have impeded its widespread implementation to date. A variety of overlapping concepts coexist in the literature, which have the potential to impair both clinical and research agendas. The aim of this article is therefore to explore the meaning of the concept of care planning in relation to other overlapping concepts and how this translates into clinical practice implementation.Methods
Searches were conducted in the Cochrane database for systematic reviews, CINHAL and MEDLINE. A staged approach to conducting the concept mapping was undertaken, by (i) an examination of the literature on care planning in LTCs; (ii) identification of related terms; (iii) locating reviews of those terms. Retrieved articles were subjected to a content analysis, which formed the basis of our concept maps. (iv) We then appraised these against knowledge and experience of the implementation of care planning in clinical practice.Results and Conclusions
Thirteen articles were retrieved, in which the core importance of patient‐centredness, shared decision making and self‐management was highlighted. Literature searches on these terms retrieved a further 24 articles. Our concept mapping exercise shows that whilst there are common themes across the concepts, the differences between them reflect the context and intended outcomes within clinical practice. We argue that this clarification exercise will allow for further development of both research and clinical implementation agendas. 相似文献76.
77.
Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer 总被引:3,自引:3,他引:3
Onishi M; Mui AL; Morikawa Y; Cho L; Kinoshita S; Nolan GP; Gorman DM; Miyajima A; Kitamura T 《Blood》1996,88(4):1399-1406
Thrombopoietin and its receptor (MPL) are important regulators of megakaryopoiesis. We have identified an activating mutation of MPL using a combination of a retrovirus-mediated gene transfer and polymerase chain reaction-driven random mutagenesis. This point mutation causes a single amino acid substitution from Ser498 to Asn498 in the transmembrane region and abrogates factor-dependency of all interleukin-3-dependent cell lines tested. Murine interleukin-3- dependent Ba/F3 cells expressing the mutated but not the normal form of MPL were tumorigenic when transduced into syngeneic mice. Analysis of intracellular signaling pathways indicated that the mutant MPL protein constitutively activated two distinct signaling pathways, SHC-Raf-MAPK and JAK2-STAT3/STAT5. 相似文献
78.
Role of copper in mitochondrial iron metabolism 总被引:1,自引:1,他引:1
Heme synthesis by copper-deficient cells was investigated to elucidate the nature of the defect in intracellular iron metabolism. Iron uptake from transferrin by copper-deficient reticulocytes was 52% of normal, and the rate of heme synthesis was 33% of normal. Hepatic mitochondria isolated from copper-deficient animals were deficient in cytochrome oxidase activity and failed to synthesize heme from ferric iron (Fe III) and protoporphyrin at the normal rate. The rate of heme synthesis correlated with the cytochrome oxidase activity. Heme synthesis from Fe(III) and protoporphyrin by normal mitochondria was enhanced by succinate and inhibited by malonate, antimycin A, azide, and cyanide. It is proposed that an intact electron transport system is required for the reduction of Fe(III), thereby providing a pool of ferrous iron (Fe II) for protoheme and heme a synthesis. 相似文献
79.
N. Turgeon J.A. Fishman M. Doran N. Basgoz N.E. Tolkoff-Rubin A.B. Cosimi R.H. Rubin 《Transplant infectious disease》2000,2(1):2-10
Background: Although the primary treatment of symptomatic cytomegalovirus (CMV) disease in organ transplant recipients is successful in >90% of individuals, relapsing disease, particularly in those with primary infection, remains an important problem. Previously, we had observed that the rate of symptomatic recurrence was >60% in those with primary disease (seronegative for CMV prior to transplant), and approximately 20% in those who were seropositive prior to transplant. The present study was undertaken to determine whether a maintenance regimen of oral ganciclovir for 2–3 months added to the routine 14–21 days of intravenous ganciclovir would further prevent symptomatic CMV recurrence. Methods: From May 1995 until June 1998, all kidney and liver transplant recipients with confirmed tissue‐invasive CMV disease or CMV syndrome were treated with 14–21 days of intravenous ganciclovir (5 mg/kg b.i.d. with dose adjusted for renal dysfunction) followed by 2–3 months of oral ganciclovir (2 g daily). The incidence of recurrence of CMV disease and/or viremia during and after oral therapy was then determined over a mean follow‐up of 530.6 days. Results: Thirty‐seven patients, 19 kidney and 18 liver transplant recipients, were studied; 5 had biopsy‐proven tissue‐invasive disease (13.5) and 32 suffered a CMV syndrome (86.5). Twenty‐one of these patients (58.6) were seronegative for CMV prior to transplant and received an allograft from a seropositive donor (D+/R?). Overall, 10 patients (27.0) developed CMV recurrence. Eight of 21 patients who were D+/R? for CMV (38.1) developed recurrence as opposed to 2 of 16 patients with other serologic status (12.5) (P=0.14). Patients with recurrent CMV disease and/or viremia had a peak antigenemia assay titer during their initial CMV event of 319.2 positive cells/2 slides compared with 109.8 positive cells/2 slides for patients without recurrent CMV infection (P=0.14); the trend of having a higher peak antigenemia assay titer among patients who recurred occurred both in patients who were at risk of primary CMV infection (D+/R? for CMV) and in those who were not. Two patients developed recurrent infection with strains of CMV that were resistant to ganciclovir. Conclusions: This new therapeutic regimen of oral ganciclovir following intravenous ganciclovir slightly reduced the overall rate of recurrent CMV disease and/or viremia, but it still did not adequately prevent CMV recurrence in patients who are at risk of primary infection prior to transplant. Of particular concern, 2 patients with primary infection treated with this regimen developed ganciclovir‐resistant recurrent disease ( Note Presented in part at the American Society of Transplant Physicians Meeting, May 1999, Chicago, Illinois.
). 相似文献
). 相似文献
80.